Albuterol delivered by metered-dose inhaler (MDI), MDI with spacer, and Rotahaler® device - A comparison of efficacy and safety

Journal of Asthma

Volumn 35, Issue 4, 1998, Pages 373-379

  Golish, Joseph ^a   Curtis McCarthy, Patricia ^a   McCarthy, Kevin ^a   Kavuru, Mani ^a   Wagner, William ^a   Beck, Gerald ^a   Eng, Phillip ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; SALBUTAMOL;

ADULT; AGED; ARTICLE; ASTHMA; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVICE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; HEART RATE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; METERED DOSE INHALER; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY;

EID: 0031730833     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.3109/02770909809075671     Document Type: Article

References (28)

1. Mestiz H, Copland JM, McDonald CF: Comparison of outpatient nebulized vs metered dose inhaler terbutaline in chronic airflow obstruction. Chest 96:1237-1240 (1989).
2. Christensson P, Arborelius M, Lilja B: Salbutamol inhalation in chronic asthma: dose aerosol vs jet nebulizer. Chest 79:416-119 (1981).
3. Newman SP, Pavia D, Moren F, Sheahan NF, Clarke SW: Deposition of pressurized aerosols in the human respiratory tract. Thorax 36:52-55 (1981).
4. Newman SP: Aerosol deposition considerations in inhalation therapy. Chest 88(S):152S-160S (1985).
5. Lewis RA, Fleming JS: Fractional deposition from a jet nebulizer: how it differs from a metered dose inhaler. Br J Dis Chest 79:361-367 (1985).
6. Allen SC, Prior A: What determines whether an elderly patient can use a metered dose inhaler correctly? Br J Dis Chest 80:45-49 (1986).
7. Armitage JM, Williams SJ: Inhaler technique in the elderly. Ageing 17:275-278 (1988).
8. Shim C, Williams MH: The adequacy of inhalation of aerosol from canister nebulizers. Am J Med 69: 891-896 (1980).
9. Orehek J, Gayrard P, Grimand CH, Charpin J: Patient error in the use of bronchodilator metered aerosols. Br Med J 1:76-77 (1976).
10. Epstein SW, Manning CPR, Ashley MJ, Corey PN: Survey of the clinical use of pressurized aerosol inhalers. Can Med Assoc J 120:813-816 (1979).
11. Crapo RO, Morris AH, Gardner RM: Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 123:659-664 (1981).
12. Dolovich M, Ruffin R, Corr D, Newhouse MT: Clinical evaluation of a simple demand inhalation MDI aerosol delivery device. Chest 84:36-41 (1983).
13. Konig P: Spacer devices used with metered dose inhalers: Breakthrough or gimmick? Chest 88:276-284 (1985).
14. Sackner MA, Kim CS: Recent advances in the management of obstructive airways disease: auxiliary MDI aerosol delivery systems. Chest 88(S):161S-170S (1985).
15. Crimi N, Palermo F, Cacopardo B, Vancheri C, Oliver R, Palermo B, et al: Bronchodilator effect of Aerochamber and InspirEase in comparison with metered dose inhaler. Eur J Respir Dis 71:153-157 (1987).
16. Lee H, Evans HE: Evaluation of inhalational aids of metered dose inhalers in asthmatic children. Chest 91:366-369 (1987).
17. Tschopp JM, Robinson S, Carloz JM, Frey JG: Bronchodilating efficacy of an open-spacer device compared to three other spacers. Respir Care 37:61-64 (1992).
18. Balmes JR: Propellant gases in metered dose inhalers: their impact on the global environment. Respir Care 36:1037-1044 (1991).
19. Balmes JR: The environmental impact of chlorofluorocarbon use in metered dose inhalers. Chest 100: 1101-1102 (1991).
20. Newman SP: Metered dose pressurized aerosols and the ozone layer. Eur Respir J 3:495-497 (1990).
21. Muittari A, Ahonen A: Comparison of the bronchodilator effect of inhaled salbutamol powder and pressurized salbutamol aerosol. Curr Ther Res 25: 804-808 (1979).
22. Bronsky E, Bucholtz GA, Busse WW, Chervinsky P, Condemi J, Ghafouri MA, et al: Comparison of inhaled albuterol powder and aerosol in asthma. J Allergy Clin Immunol 79:741-747 (1987).
23. Sovijarvi ARA, Lahdensuo A, Muittari A: Bronchodilating effect of salbutamol inhalation powder and salbutamol aerosol after methacholine-induced bronchoconstriction. Curr Ther Res 32:566-573 (1982).
24. Tukainen H, Terho EO: Comparison of inhaled salbutamol powder and aerosol in asthmatic patients with low peak expiratory flow level. Eur J Clin Pharmacol 27:645-647 (1985).
25. Fuller HD: Comparison of two chamber devices in patients using a metered dose inhaler with satisfactory technique. Can Med Assoc J 135:625-629 (1986).
26. O'Reilly JF, Gould G, Kendrick AH, Laszlo G: Domiciliary comparison of terbutaline treatment by metered dose inhaler with and without conical spacer in severe and moderately severe chronic asthma. Thorax 41:766-770 (1986).
27. Sears MR, Taylor DR, Print CG, Lake DC, Li QQ, Flannery EM, et al: Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 336:1391-1396 (1990).
28. Hansen NCG: Terbutaline as powder inhalation from Bricanyl Turbuhaler compared to terbutaline as nebulizer solution in severe chronic airways obstruction. Eur Respir J 2(S):716-720 (1989).